corinorx.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# Robots.txt file from http://www.03f8a50.netsolhost.com Sitemap: http://www.03f8a50.netsolhost.com/sitemap.xml User-agent: *
Meta Tags
Title Corino Therapeutics Home
Description Search Results Area of Focus Our Pipeline Delivering on the Needs of Patients Corino Therapeutics, Inc. is a private, development-stage biopharmaceutical
Keywords Transthyretin, orphan drug, pharmaceutical company, amyloidosis, TTR, polyneuropathy, cardiomyopathy, leptomeningeal, ATTR
Server Information
WebSite corinorx faviconcorinorx.com
Host IP 206.188.192.74
Location United States
Related Websites
Site Rank
More to Explore
corinorx.com Valuation
US$1,575,805
Last updated: 2023-05-18 12:34:18

corinorx.com has Semrush global rank of 6,716,763. corinorx.com has an estimated worth of US$ 1,575,805, based on its estimated Ads revenue. corinorx.com receives approximately 181,824 unique visitors each day. Its web server is located in United States, with IP address 206.188.192.74. According to SiteAdvisor, corinorx.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,575,805
Daily Ads Revenue US$1,455
Monthly Ads Revenue US$43,638
Yearly Ads Revenue US$523,652
Daily Unique Visitors 12,122
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
corinorx.com. A 7200 IP: 206.188.192.74
corinorx.com. NS 7200 NS Record: ns58.worldnic.com.
corinorx.com. NS 7200 NS Record: ns57.worldnic.com.
corinorx.com. MX 7200 MX Record: 10 mx1.netsolmail.net.
corinorx.com. TXT 3600 TXT Record: MS=ms23998094
HtmlToTextCheckTime:2023-05-18 12:34:18
Search Results Area of Focus Our Pipeline Delivering on the Needs of Patients Corino Therapeutics, Inc. is a private, development-stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative products for the treatment of a variety of human diseases, particularly orphan indications. Corino develops technologies that address important unmet medical needs, and which offer improved, cost-effective alternatives to current methods of treatment. Developing a Novel Treatment for ATTR ATTR-Cardiomyopathy hATTR-Polyneuropathy hATTR-Leptomeningeal W e are developing a disease modifying drug called CRX-1008 . CRX-1008 is a potent small molecule TTR stablizer. CRX-1008 is given orally to patients and may treat both peripheral and central ATTR. We have completed multiple clinical proof of concept studies to evaluate the safety, tolerability, and TTR stabilization activity of CRX-1008 . Data from these studies are expected this year as we plan for Phase 2/3
HTTP Headers
HTTP/1.1 200 OK
Server: openresty/1.19.9.1
Date: Sat, 18 Jun 2022 08:28:33 GMT
Content-Type: text/html
Content-Length: 52590
Connection: keep-alive
Vary: Accept-Encoding
Last-Modified: Wed, 26 Feb 2020 20:12:45 GMT
ETag: "cd6e-59f803a45f78f"
X-Webcom-Cache-Status: BYPASS
Accept-Ranges: bytes
corinorx.com Whois Information
Domain Name: CORINORX.COM
Registry Domain ID: 2075219471_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2021-09-19T08:41:30Z
Creation Date: 2016-11-18T20:36:16Z
Registry Expiry Date: 2022-11-18T20:36:16Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS57.WORLDNIC.COM
Name Server: NS58.WORLDNIC.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-06-18T08:24:51Z <<<